steffimycin

see also record for steffimycin B; structure

Also Known As:

U-20661

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        steffimycin: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - steffimycin: 1
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - steffimycin: 1

Experts

1.	Abdelfattah, Mohamed S: 1 article (03/2008)
2.	Braña, Alfredo F: 1 article (03/2008)
3.	Gullón, Sonia: 1 article (03/2008)
4.	Méndez, Carmen: 1 article (03/2008)
5.	Olano, Carlos: 1 article (03/2008)
6.	Rohr, Jürgen: 1 article (03/2008)
7.	Salas, José A: 1 article (03/2008)

Related Diseases

1.	Colonic Neoplasms (Colon Cancer) 03/03/2008 - "Analysis of the biological activities of these compounds against three human tumor cell lines-breast adenocarcinoma, non-small cell lung cancer, and colon adenocarcinoma-revealed two of them, 3'-O-methylsteffimycin and D-digitoxosyl-8-demethoxy-10-deoxysteffimycinone, to possess improved antitumor activities, showing GI50 values below 1.0 microM, while steffimycin's GI50 values fluctuate between 2.61 to 6.79 microM depending upon the cell line used. "
2.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/03/2008 - "Analysis of the biological activities of these compounds against three human tumor cell lines-breast adenocarcinoma, non-small cell lung cancer, and colon adenocarcinoma-revealed two of them, 3'-O-methylsteffimycin and D-digitoxosyl-8-demethoxy-10-deoxysteffimycinone, to possess improved antitumor activities, showing GI50 values below 1.0 microM, while steffimycin's GI50 values fluctuate between 2.61 to 6.79 microM depending upon the cell line used. "
3.	Adenocarcinoma 03/03/2008 - "Analysis of the biological activities of these compounds against three human tumor cell lines-breast adenocarcinoma, non-small cell lung cancer, and colon adenocarcinoma-revealed two of them, 3'-O-methylsteffimycin and D-digitoxosyl-8-demethoxy-10-deoxysteffimycinone, to possess improved antitumor activities, showing GI50 values below 1.0 microM, while steffimycin's GI50 values fluctuate between 2.61 to 6.79 microM depending upon the cell line used. "